We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Becton Dickinson and Company | NYSE:BDX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 234.60 | 1 | 12:00:00 |
FRANKLIN LAKES, N.J., Aug. 3, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2019 Sustainability Report, focusing on performance of the environmental, social and governance factors that support the company's 2020 Sustainability Goals from October 1, 2018 to September 30, 2019 (FY 2019).
BD's sustainability strategy is driven by its purpose – Advancing the world of health™ – and provides the framework for how it manages, and makes an impact on, the most relevant social and environmental issues for the company and its stakeholders.
Highlights from this year's report include:
"We are proud of our accomplishments in FY 2019, but we will never be satisfied with maintaining the status quo," said Tom Polen, CEO and president. "Just as we continuously seek new innovations to help more patients live better lives, we strive to be the best employer, the best environmental steward and the best global corporate citizen we can possibly be."
The company will announce new sustainability commitments later in FY 2021 which will focus on shared value creation – addressing unmet societal needs through business models and initiatives that also contribute to commercial success. For more information about the company's sustainability goals, view the 2019 Sustainability Report here: https://www.bd.com/en-us/company/sustainability-at-bd.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.
Contacts: | |
Jessica Offerjost | Monique N. Dolecki |
BD Public Relations | BD Investor Relations |
201-258-0964 | 201.847.5378 |
Jessica.Offerjost@bd.com | Monique_Dolecki@bd.com |
View original content to download multimedia:http://www.prnewswire.com/news-releases/bd-releases-fy-2019-sustainability-report-301104250.html
SOURCE BD (Becton, Dickinson and Company)
Copyright 2020 PR Newswire
1 Year Becton Dickinson Chart |
1 Month Becton Dickinson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions